Table 3 All-cause and cause-specific mortality according to advanced fibrosis
| Â | N | Death | Duration (PYs) | Incidence rate (per 1000 PY) | Hazard ratio (95% confidence interval) | |
|---|---|---|---|---|---|---|
Model 1 | Model 2 | |||||
All Cause of mortality | ||||||
 FLI < 60 | 1,491,740 | 176,735 | 11572947.32 | 15.27 | 1(Ref.) | 1(Ref.) |
 FLI ≥ 60, BARD < 2 | 111,425 | 6,664 | 882056.70 | 7.56 | 0.94 (0.91, 0.96) | 0.96 (0.93, 0.98) |
 FLI ≥ 60, BARD ≥ 2 | 404,610 | 38,843 | 3139790.96 | 12.37 | 1.08 (1.07, 1.09) | 1.11 (1.10, 1.12) |
CVD-specific mortality | ||||||
 FLI < 60 | 1,491,740 | 38,217 | 11572947.32 | 3.30 | 1(Ref.) | 1(Ref.) |
 FLI ≥ 60, BARD < 2 | 111,425 | 1,345 | 882056.70 | 1.52 | 1.00 (0.95, 1.06) | 1.12 (1.05, 1.18) |
 FLI ≥ 60, BARD ≥ 2 | 404,610 | 8,006 | 3139790.96 | 2.55 | 1.08 (1.06, 1.11) | 1.11 (1.09, 1.14) |
Cancer-specific mortality | ||||||
 FLI < 60 | 1,491,740 | 50,087 | 11572947.32 | 4.33 | 1(Ref.) | 1(Ref.) |
 FLI ≥ 60, BARD < 2 | 111,425 | 2,327 | 882056.70 | 2.64 | 0.96 (0.92, 1.00) | 0.90 (0.87, 0.94) |
 FLI ≥ 60, BARD ≥ 2 | 404,610 | 12,920 | 3139790.96 | 4.11 | 1.18 (1.16, 1.20) | 1.17 (1.15, 1.19) |
Respiratory disease-related mortality | ||||||
 FLI < 60 | 1,491,740 | 18,445 | 11572947.32 | 1.59 | 1 (Ref.) | 1 (Ref.) |
 FLI ≥ 60, BARD < 2 | 111,425 | 424 | 882056.70 | 0.48 | 0.72 (0.65, 0.79) | 0.89 (0.80, 0.98) |
 FLI ≥ 60, BARD ≥ 2 | 404,610 | 2,865 | 3139790.96 | 0.91 | 0.85 (0.81, 0.88) | 0.95 (0.91, 0.99) |
Liver disease-related mortality | ||||||
 FLI < 60 | 1,491,740 | 6,343 | 11572947.32 | 0.55 | 1(Ref.) | 1(Ref.) |
 FLI ≥ 60, BARD < 2 | 111,425 | 484 | 882056.70 | 0.55 | 1.29 (1.18, 1.42) | 1.08 (0.99, 1.19) |
 FLI ≥ 60, BARD ≥ 2 | 404,610 | 3,780 | 3139790.96 | 1.20 | 2.51 (2.41, 2.61) | 2.38 (2.29, 2.49) |